AU2003242428A1 - Drugs improved in tissue selectivity - Google Patents

Drugs improved in tissue selectivity

Info

Publication number
AU2003242428A1
AU2003242428A1 AU2003242428A AU2003242428A AU2003242428A1 AU 2003242428 A1 AU2003242428 A1 AU 2003242428A1 AU 2003242428 A AU2003242428 A AU 2003242428A AU 2003242428 A AU2003242428 A AU 2003242428A AU 2003242428 A1 AU2003242428 A1 AU 2003242428A1
Authority
AU
Australia
Prior art keywords
tissue selectivity
drugs improved
drugs
improved
selectivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003242428A
Inventor
Yoshiyuki Fujimura
Yasuhiro Kuwahara
Yukiko Nishimura
Kouichi Sekiya
Ken Ubasawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2003242428A1 publication Critical patent/AU2003242428A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003242428A 2002-05-24 2003-05-23 Drugs improved in tissue selectivity Abandoned AU2003242428A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002151506 2002-05-24
JP2002-151507 2002-05-24
JP2002-151506 2002-05-24
JP2002151507 2002-05-24
PCT/JP2003/006463 WO2003099294A1 (en) 2002-05-24 2003-05-23 Drugs improved in tissue selectivity

Publications (1)

Publication Number Publication Date
AU2003242428A1 true AU2003242428A1 (en) 2003-12-12

Family

ID=29585976

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003242428A Abandoned AU2003242428A1 (en) 2002-05-24 2003-05-23 Drugs improved in tissue selectivity

Country Status (3)

Country Link
AU (1) AU2003242428A1 (en)
TW (1) TW200402299A (en)
WO (1) WO2003099294A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101745B2 (en) 2004-12-16 2012-01-24 The Regents Of The University Of California Lung-targeted drugs
DK2794624T3 (en) 2011-12-22 2019-07-22 Geron Corp Guanine analogues such as telomerase substrates and telomere length influencers
WO2014143643A1 (en) 2013-03-15 2014-09-18 The Regents Of The University Of California, A California Corporation Acyclic nucleoside phosphonate diesters
EA036391B1 (en) 2014-09-15 2020-11-05 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Nucleotide analogs
WO2017048956A1 (en) 2015-09-15 2017-03-23 The Regents Of The University Of California Nucleotide analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426418A (en) * 2000-02-29 2003-06-25 三菱制药株式会社 Phosphate nucleotide compound'

Also Published As

Publication number Publication date
WO2003099294A1 (en) 2003-12-04
TW200402299A (en) 2004-02-16

Similar Documents

Publication Publication Date Title
EP2289512B8 (en) Pharmaceutical foam
AU2003217740A1 (en) Non-invasive stationary system
AU2003249176A1 (en) Multilayered tissue products
AU2003281505A1 (en) Chair
AU2003246734A1 (en) Medicament dispenser
AU2003246722A1 (en) Medicament dispenser
AU2003276447A1 (en) Inhalers
AU2003229738A1 (en) Medicament dispenser
AU2003269018A1 (en) Acylaminothiazole derivatives, preparation and therapeutic use thereof
AU2003248153A1 (en) Honey-based skin care preparation
AU2003255372A1 (en) Medical device
AU2003233083A1 (en) Medicament dispenser
AU2003264406A1 (en) Drug or cosmetic
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003264541A1 (en) Medical material
AU2003242428A1 (en) Drugs improved in tissue selectivity
AU2003213146A1 (en) Activated protein c formulations
AU2003256112A1 (en) Patient bed
AU2003900495A0 (en) Aroylhydrazone derivatives and therapeutic uses thereof
AU2003229499A1 (en) Disposable barbecue
AU2003283533A1 (en) Medicated comestibles
AU2003268985A1 (en) Cannula
AU2003231937A1 (en) Therapeutic methods
AU2003241937A1 (en) Examination chair
AU2003229752A1 (en) Human rhomboid-related protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase